APO Research
Talk to an analyst

APO RESEARCH · REPORT

Integrin Alpha 4

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Integrin Alpha 4 Industry Growth and Trends Forecast to 2032

26 December 2025109 pages

Choose your research edition.

Industry ResearchIntegrin Alpha 4 Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Integrin Alpha 4 Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Integrin Alpha 4 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Integrin Alpha 4 Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Integrin Alpha 4 Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Integrin Alpha 4 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Integrin Alpha 4 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Integrin Alpha 4 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Integrin Alpha 4 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Integrin Alpha 4 include Takeda Pharmaceutical Co Ltd, Viriom Inc, Protagonist Therapeutics Inc, Morphic Therapeutic Inc, Immunwork Inc, EA Pharma Co Ltd, Daiichi Sankyo Co Ltd, BioMAS Ltd and Biogen Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Integrin Alpha 4 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Integrin Alpha 4 market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Integrin Alpha 4 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Integrin Alpha 4.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Integrin Alpha 4 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Integrin Alpha 4 Market by Company

Takeda Pharmaceutical Co Ltd

Viriom Inc

Protagonist Therapeutics Inc

Morphic Therapeutic Inc

Immunwork Inc

EA Pharma Co Ltd

Daiichi Sankyo Co Ltd

BioMAS Ltd

Biogen Inc

Antisense Therapeutics Ltd

Amgen Inc

Integrin Alpha 4 Segment by Type

ATL-1102

Carotegrast

ET-3764

TE-5232

Others

Integrin Alpha 4 Segment by Application

Acute Ischemic Stroke

Melanoma

Celiac Disease

Multiple Sclerosis

Epilepsy

Other

Integrin Alpha 4 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Integrin Alpha 4 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Integrin Alpha 4 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Integrin Alpha 4.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Integrin Alpha 4 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Integrin Alpha 4 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of ATL-1102 Table 2. Major Company of Carotegrast Table 3. Major Company of ET-3764 Table 4. Major Company of TE-5232 Table 5. Major Company of Others Table 6. Global Integrin Alpha 4 Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Integrin Alpha 4 Sales by Type (2021-2026) & (W Units) Table 8. Global Integrin Alpha 4 Sales Market Share in Volume by Type (2021-2026) Table 9. Global Integrin Alpha 4 Sales by Type (2021-2026) & (US$ Million) Table 10. Global Integrin Alpha 4 Sales Market Share in Value by Type (2021-2026) Table 11. Global Integrin Alpha 4 Price by Type (2021-2026) & (US$/Unit) Table 12. Global Integrin Alpha 4 Sales by Type (2027-2032) & (W Units) Table 13. Global Integrin Alpha 4 Sales Market Share in Volume by Type (2027-2032) Table 14. Global Integrin Alpha 4 Sales by Type (2027-2032) & (US$ Million) Table 15. Global Integrin Alpha 4 Sales Market Share in Value by Type (2027-2032) Table 16. Global Integrin Alpha 4 Price by Type (2027-2032) & (US$/Unit) Table 17. North America Integrin Alpha 4 Sales by Type (2021-2026) & (W Units) Table 18. North America Integrin Alpha 4 Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Integrin Alpha 4 Sales by Type (2021-2026) & (W Units) Table 20. Europe Integrin Alpha 4 Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Integrin Alpha 4 Sales by Type (2021-2026) & (W Units) Table 22. Asia-Pacific Integrin Alpha 4 Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Integrin Alpha 4 Sales by Type (2021-2026) & (W Units) Table 24. Latin America Integrin Alpha 4 Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Integrin Alpha 4 Sales by Type (2021-2026) & (W Units) Table 26. Middle East and Africa Integrin Alpha 4 Sales by Type (2021-2026) & (US$ Million) Table 27. Integrin Alpha 4 Industry Trends Table 28. Integrin Alpha 4 Industry Drivers Table 29. Integrin Alpha 4 Industry Opportunities and Challenges Table 30. Integrin Alpha 4 Industry Restraints Table 31. Global Integrin Alpha 4 Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Integrin Alpha 4 Revenue Market Share by Company (2021-2026) Table 33. Global Integrin Alpha 4 Sales by Company (2021-2026) & (W Units) Table 34. Global Integrin Alpha 4 Sales Share by Company (2021-2026) Table 35. Global Integrin Alpha 4 Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Integrin Alpha 4 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Integrin Alpha 4 Major Company Production Sites and Headquarters Table 38. Global Integrin Alpha 4 Company, Product Type & Application Table 39. Global Integrin Alpha 4 Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Integrin Alpha 4 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Integrin Alpha 4 Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Integrin Alpha 4 Sales by Region (2021-2026) & (W Units) Table 44. Global Integrin Alpha 4 Sales Market Share in Volume by Region (2021-2026) Table 45. Global Integrin Alpha 4 Sales by Region (2021-2026) & (US$ Million) Table 46. Global Integrin Alpha 4 Sales Market Share in Value by Region (2021-2026) Table 47. Global Integrin Alpha 4 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Integrin Alpha 4 Sales by Region (2027-2032) & (W Units) Table 49. Global Integrin Alpha 4 Sales Market Share in Volume by Region (2027-2032) Table 50. Global Integrin Alpha 4 Sales by Region (2027-2032) & (US$ Million) Table 51. Global Integrin Alpha 4 Sales Market Share in Value by Region (2027-2032) Table 52. Global Integrin Alpha 4 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Integrin Alpha 4 Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Integrin Alpha 4 Sales by Application (2021-2026) & (W Units) Table 55. Global Integrin Alpha 4 Sales Market Share in Volume by Application (2021-2026) Table 56. Global Integrin Alpha 4 Sales by Application (2021-2026) & (US$ Million) Table 57. Global Integrin Alpha 4 Sales Market Share in Value by Application (2021-2026) Table 58. Global Integrin Alpha 4 Price by Application (2021-2026) & (US$/Unit) Table 59. Global Integrin Alpha 4 Sales by Application (2027-2032) & (W Units) Table 60. Global Integrin Alpha 4 Sales Market Share in Volume by Application (2027-2032) Table 61. Global Integrin Alpha 4 Sales by Application (2027-2032) & (US$ Million) Table 62. Global Integrin Alpha 4 Sales Market Share in Value by Application (2027-2032) Table 63. Global Integrin Alpha 4 Price by Application (2027-2032) & (US$/Unit) Table 64. North America Integrin Alpha 4 Sales by Application (2021-2026) & (W Units) Table 65. North America Integrin Alpha 4 Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Integrin Alpha 4 Sales by Application (2021-2026) & (W Units) Table 67. Europe Integrin Alpha 4 Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Integrin Alpha 4 Sales by Application (2021-2026) & (W Units) Table 69. Asia-Pacific Integrin Alpha 4 Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Integrin Alpha 4 Sales by Application (2021-2026) & (W Units) Table 71. Latin America Integrin Alpha 4 Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Integrin Alpha 4 Sales by Application (2021-2026) & (W Units) Table 73. Middle East and Africa Integrin Alpha 4 Sales by Application (2021-2026) & (US$ Million) Table 74. Takeda Pharmaceutical Co Ltd Company Information Table 75. Takeda Pharmaceutical Co Ltd Business Overview Table 76. Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Product Portfolio Table 78. Takeda Pharmaceutical Co Ltd Recent Development Table 79. Viriom Inc Company Information Table 80. Viriom Inc Business Overview Table 81. Viriom Inc Integrin Alpha 4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Viriom Inc Integrin Alpha 4 Product Portfolio Table 83. Viriom Inc Recent Development Table 84. Protagonist Therapeutics Inc Company Information Table 85. Protagonist Therapeutics Inc Business Overview Table 86. Protagonist Therapeutics Inc Integrin Alpha 4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Protagonist Therapeutics Inc Integrin Alpha 4 Product Portfolio Table 88. Protagonist Therapeutics Inc Recent Development Table 89. Morphic Therapeutic Inc Company Information Table 90. Morphic Therapeutic Inc Business Overview Table 91. Morphic Therapeutic Inc Integrin Alpha 4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Morphic Therapeutic Inc Integrin Alpha 4 Product Portfolio Table 93. Morphic Therapeutic Inc Recent Development Table 94. Immunwork Inc Company Information Table 95. Immunwork Inc Business Overview Table 96. Immunwork Inc Integrin Alpha 4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Immunwork Inc Integrin Alpha 4 Product Portfolio Table 98. Immunwork Inc Recent Development Table 99. EA Pharma Co Ltd Company Information Table 100. EA Pharma Co Ltd Business Overview Table 101. EA Pharma Co Ltd Integrin Alpha 4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. EA Pharma Co Ltd Integrin Alpha 4 Product Portfolio Table 103. EA Pharma Co Ltd Recent Development Table 104. Daiichi Sankyo Co Ltd Company Information Table 105. Daiichi Sankyo Co Ltd Business Overview Table 106. Daiichi Sankyo Co Ltd Integrin Alpha 4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Daiichi Sankyo Co Ltd Integrin Alpha 4 Product Portfolio Table 108. Daiichi Sankyo Co Ltd Recent Development Table 109. BioMAS Ltd Company Information Table 110. BioMAS Ltd Business Overview Table 111. BioMAS Ltd Integrin Alpha 4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. BioMAS Ltd Integrin Alpha 4 Product Portfolio Table 113. BioMAS Ltd Recent Development Table 114. Biogen Inc Company Information Table 115. Biogen Inc Business Overview Table 116. Biogen Inc Integrin Alpha 4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Biogen Inc Integrin Alpha 4 Product Portfolio Table 118. Biogen Inc Recent Development Table 119. Antisense Therapeutics Ltd Company Information Table 120. Antisense Therapeutics Ltd Business Overview Table 121. Antisense Therapeutics Ltd Integrin Alpha 4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Antisense Therapeutics Ltd Integrin Alpha 4 Product Portfolio Table 123. Antisense Therapeutics Ltd Recent Development Table 124. Amgen Inc Company Information Table 125. Amgen Inc Business Overview Table 126. Amgen Inc Integrin Alpha 4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Amgen Inc Integrin Alpha 4 Product Portfolio Table 128. Amgen Inc Recent Development Table 129. North America Integrin Alpha 4 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 130. North America Integrin Alpha 4 Sales by Country (2021-2026) & (W Units) Table 131. North America Integrin Alpha 4 Sales Market Share by Country (2021-2026) Table 132. North America Integrin Alpha 4 Sales Forecast by Country (2027-2032) & (W Units) Table 133. North America Integrin Alpha 4 Sales Market Share Forecast by Country (2027-2032) Table 134. North America Integrin Alpha 4 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. North America Integrin Alpha 4 Market Size by Country (2021-2026) & (US$ Million) Table 136. North America Integrin Alpha 4 Market Share by Country (2021-2026) Table 137. North America Integrin Alpha 4 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. North America Integrin Alpha 4 Market Share Forecast by Country (2027-2032) Table 139. Europe Integrin Alpha 4 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 140. Europe Integrin Alpha 4 Sales by Country (2021-2026) & (W Units) Table 141. Europe Integrin Alpha 4 Sales Market Share by Country (2021-2026) Table 142. Europe Integrin Alpha 4 Sales Forecast by Country (2027-2032) & (W Units) Table 143. Europe Integrin Alpha 4 Sales Market Share Forecast by Country (2027-2032) Table 144. Europe Integrin Alpha 4 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Europe Integrin Alpha 4 Market Size by Country (2021-2026) & (US$ Million) Table 146. Europe Integrin Alpha 4 Market Share by Country (2021-2026) Table 147. Europe Integrin Alpha 4 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Europe Integrin Alpha 4 Market Share Forecast by Country (2027-2032) Table 149. Asia-Pacific Integrin Alpha 4 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 150. Asia-Pacific Integrin Alpha 4 Sales by Country (2021-2026) & (W Units) Table 151. Asia-Pacific Integrin Alpha 4 Sales Market Share by Country (2021-2026) Table 152. Asia-Pacific Integrin Alpha 4 Sales Forecast by Country (2027-2032) & (W Units) Table 153. Asia-Pacific Integrin Alpha 4 Sales Market Share Forecast by Country (2027-2032) Table 154. Asia-Pacific Integrin Alpha 4 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Asia-Pacific Integrin Alpha 4 Market Size by Country (2021-2026) & (US$ Million) Table 156. Asia-Pacific Integrin Alpha 4 Market Share by Country (2021-2026) Table 157. Asia-Pacific Integrin Alpha 4 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Asia-Pacific Integrin Alpha 4 Market Share Forecast by Country (2027-2032) Table 159. Latin America Integrin Alpha 4 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 160. Latin America Integrin Alpha 4 Sales by Country (2021-2026) & (W Units) Table 161. Latin America Integrin Alpha 4 Sales Market Share by Country (2021-2026) Table 162. Latin America Integrin Alpha 4 Sales Forecast by Country (2027-2032) & (W Units) Table 163. Latin America Integrin Alpha 4 Sales Market Share Forecast by Country (2027-2032) Table 164. Latin America Integrin Alpha 4 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Latin America Integrin Alpha 4 Market Size by Country (2021-2026) & (US$ Million) Table 166. Latin America Integrin Alpha 4 Market Share by Country (2021-2026) Table 167. Latin America Integrin Alpha 4 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Latin America Integrin Alpha 4 Market Share Forecast by Country (2027-2032) Table 169. Middle East and Africa Integrin Alpha 4 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 170. Middle East and Africa Integrin Alpha 4 Sales by Country (2021-2026) & (W Units) Table 171. Middle East and Africa Integrin Alpha 4 Sales Market Share by Country (2021-2026) Table 172. Middle East and Africa Integrin Alpha 4 Sales Forecast by Country (2027-2032) & (W Units) Table 173. Middle East and Africa Integrin Alpha 4 Sales Market Share Forecast by Country (2027-2032) Table 174. Middle East and Africa Integrin Alpha 4 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 175. Middle East and Africa Integrin Alpha 4 Market Size by Country (2021-2026) & (US$ Million) Table 176. Middle East and Africa Integrin Alpha 4 Market Share by Country (2021-2026) Table 177. Middle East and Africa Integrin Alpha 4 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 178. Middle East and Africa Integrin Alpha 4 Market Share Forecast by Country (2027-2032) Table 179. Key Raw Materials Table 180. Raw Materials Key Suppliers Table 181. Integrin Alpha 4 Distributors List Table 182. Integrin Alpha 4 Customers List Table 183. Research Programs/Design for This Report Table 184. Authors List of This Report Table 185. Secondary Sources Table 186. Primary Sources List of Figures Figure 1. Integrin Alpha 4 Image Figure 2. Global Integrin Alpha 4 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Integrin Alpha 4 Market Size (2021-2032) & (US$ Million) Figure 4. Global Integrin Alpha 4 Sales (2021-2032) & (W Units) Figure 5. ATL-1102 Image Figure 6. Global ATL-1102 Sales YoY Growth (2021-2032) & (W Units) Figure 7. Carotegrast Image Figure 8. Global Carotegrast Sales YoY Growth (2021-2032) & (W Units) Figure 9. ET-3764 Image Figure 10. Global ET-3764 Sales YoY Growth (2021-2032) & (W Units) Figure 11. TE-5232 Image Figure 12. Global TE-5232 Sales YoY Growth (2021-2032) & (W Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 15. Global Integrin Alpha 4 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Integrin Alpha 4 Market Share by Type 2025 VS 2032 Figure 17. North America Integrin Alpha 4 Sales Market Share in Volume by Type in 2025 Figure 18. North America Integrin Alpha 4 Sales Market Share in Value by Type in 2025 Figure 19. Europe Integrin Alpha 4 Sales Market Share in Volume by Type in 2025 Figure 20. Europe Integrin Alpha 4 Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Integrin Alpha 4 Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Integrin Alpha 4 Sales Market Share in Value by Type in 2025 Figure 23. Latin America Integrin Alpha 4 Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Integrin Alpha 4 Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Integrin Alpha 4 Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Integrin Alpha 4 Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Integrin Alpha 4 Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Acute Ischemic Stroke Image Figure 30. Global Acute Ischemic Stroke Sales YoY Growth (2021-2032) & (W Units) Figure 31. Melanoma Image Figure 32. Global Melanoma Sales YoY Growth (2021-2032) & (W Units) Figure 33. Celiac Disease Image Figure 34. Global Celiac Disease Sales YoY Growth (2021-2032) & (W Units) Figure 35. Multiple Sclerosis Image Figure 36. Global Multiple Sclerosis Sales YoY Growth (2021-2032) & (W Units) Figure 37. Epilepsy Image Figure 38. Global Epilepsy Sales YoY Growth (2021-2032) & (W Units) Figure 39. Other Image Figure 40. Global Other Sales YoY Growth (2021-2032) & (W Units) Figure 41. Global Integrin Alpha 4 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global Integrin Alpha 4 Market Share by Application 2025 VS 2032 Figure 43. North America Integrin Alpha 4 Sales Market Share in Volume by Application in 2025 Figure 44. North America Integrin Alpha 4 Sales Market Share in Value by Application in 2025 Figure 45. Europe Integrin Alpha 4 Sales Market Share in Volume by Application in 2025 Figure 46. Europe Integrin Alpha 4 Sales Market Share in Value by Application in 2025 Figure 47. Asia-Pacific Integrin Alpha 4 Sales Market Share in Volume by Application in 2025 Figure 48. Asia-Pacific Integrin Alpha 4 Sales Market Share in Value by Application in 2025 Figure 49. Latin America Integrin Alpha 4 Sales Market Share in Volume by Application in 2025 Figure 50. Latin America Integrin Alpha 4 Sales Market Share in Value by Application in 2025 Figure 51. Middle East and Africa Integrin Alpha 4 Sales Market Share in Volume by Application in 2025 Figure 52. Middle East and Africa Integrin Alpha 4 Sales Market Share in Value by Application in 2025 Figure 53. North America Integrin Alpha 4 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. North America Integrin Alpha 4 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. North America Integrin Alpha 4 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. North America Integrin Alpha 4 Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Integrin Alpha 4 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Europe Integrin Alpha 4 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Integrin Alpha 4 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe Integrin Alpha 4 Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Integrin Alpha 4 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 62. Asia-Pacific Integrin Alpha 4 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Integrin Alpha 4 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Asia-Pacific Integrin Alpha 4 Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Integrin Alpha 4 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 66. Latin America Integrin Alpha 4 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Integrin Alpha 4 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Latin America Integrin Alpha 4 Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Integrin Alpha 4 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 70. Middle East and Africa Integrin Alpha 4 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Integrin Alpha 4 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 72. Middle East and Africa Integrin Alpha 4 Market Share by Country: 2021 VS 2025 VS 2032 Figure 73. Integrin Alpha 4 Value Chain Figure 74. Key Raw Materials Price Figure 75. Manufacturing Cost Structure Figure 76. Integrin Alpha 4 Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • ATL-1102
  • Carotegrast
  • ET-3764
  • TE-5232
  • Others
Applications
  • Acute Ischemic Stroke
  • Melanoma
  • Celiac Disease
  • Multiple Sclerosis
  • Epilepsy
  • Other
Companies covered
  • Takeda Pharmaceutical Co Ltd
  • Viriom Inc
  • Protagonist Therapeutics Inc
  • Morphic Therapeutic Inc
  • Immunwork Inc
  • EA Pharma Co Ltd
  • Daiichi Sankyo Co Ltd
  • BioMAS Ltd
  • Biogen Inc
  • Antisense Therapeutics Ltd
  • Amgen Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Integrin Alpha 4 Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Integrin Alpha 4 Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Integrin Alpha 4 Market by Type
  6. 1.3.1 ATL-1102
  7. 1.3.2 Carotegrast
  8. 1.3.3 ET-3764
  9. 1.3.4 TE-5232
  10. 1.3.5 Others
  11. 1.4 Global Integrin Alpha 4 Market Size by Type
  12. 1.4.1 Global Integrin Alpha 4 Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Integrin Alpha 4 Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Integrin Alpha 4 Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Integrin Alpha 4 Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Integrin Alpha 4 Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Integrin Alpha 4 Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Integrin Alpha 4 Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Integrin Alpha 4 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Integrin Alpha 4 Industry Trends
  2. 2.2 Integrin Alpha 4 Industry Drivers
  3. 2.3 Integrin Alpha 4 Industry Opportunities and Challenges
  4. 2.4 Integrin Alpha 4 Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Integrin Alpha 4 Revenue (2021-2026)
  2. 3.2 Global Top Players by Integrin Alpha 4 Sales (2021-2026)
  3. 3.3 Global Top Players by Integrin Alpha 4 Price (2021-2026)
  4. 3.4 Global Integrin Alpha 4 Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Integrin Alpha 4 Major Company Production Sites & Headquarters
  6. 3.6 Global Integrin Alpha 4 Company, Product Type & Application
  7. 3.7 Global Integrin Alpha 4 Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Integrin Alpha 4 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Integrin Alpha 4 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Integrin Alpha 4 Tier 1, Tier 2, and Tier 3
4 Integrin Alpha 4 Regional Status and Outlook
  1. 4.1 Global Integrin Alpha 4 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Integrin Alpha 4 Historic Market Size by Region
  3. 4.2.1 Global Integrin Alpha 4 Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Integrin Alpha 4 Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Integrin Alpha 4 Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Integrin Alpha 4 Forecasted Market Size by Region
  7. 4.3.1 Global Integrin Alpha 4 Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Integrin Alpha 4 Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Integrin Alpha 4 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Integrin Alpha 4 by Application
  1. 5.1 Integrin Alpha 4 Market by Application
  2. 5.1.1 Acute Ischemic Stroke
  3. 5.1.2 Melanoma
  4. 5.1.3 Celiac Disease
  5. 5.1.4 Multiple Sclerosis
  6. 5.1.5 Epilepsy
  7. 5.1.6 Other
  8. 5.2 Global Integrin Alpha 4 Market Size by Application
  9. 5.2.1 Global Integrin Alpha 4 Market Size Overview by Application (2021-2032)
  10. 5.2.2 Global Integrin Alpha 4 Historic Market Size Review by Application (2021-2026)
  11. 5.2.3 Global Integrin Alpha 4 Forecasted Market Size by Application (2027-2032)
  12. 5.3 Key Regions Market Size by Application
  13. 5.3.1 North America Integrin Alpha 4 Sales Breakdown by Application (2021-2026)
  14. 5.3.2 Europe Integrin Alpha 4 Sales Breakdown by Application (2021-2026)
  15. 5.3.3 Asia-Pacific Integrin Alpha 4 Sales Breakdown by Application (2021-2026)
  16. 5.3.4 South America Integrin Alpha 4 Sales Breakdown by Application (2021-2026)
  17. 5.3.5 Middle East and Africa Integrin Alpha 4 Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda Pharmaceutical Co Ltd
  2. 6.1.1 Takeda Pharmaceutical Co Ltd Company Information
  3. 6.1.2 Takeda Pharmaceutical Co Ltd Business Overview
  4. 6.1.3 Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Product Portfolio
  6. 6.1.5 Takeda Pharmaceutical Co Ltd Recent Developments
  7. 6.2 Viriom Inc
  8. 6.2.1 Viriom Inc Company Information
  9. 6.2.2 Viriom Inc Business Overview
  10. 6.2.3 Viriom Inc Integrin Alpha 4 Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Viriom Inc Integrin Alpha 4 Product Portfolio
  12. 6.2.5 Viriom Inc Recent Developments
  13. 6.3 Protagonist Therapeutics Inc
  14. 6.3.1 Protagonist Therapeutics Inc Company Information
  15. 6.3.2 Protagonist Therapeutics Inc Business Overview
  16. 6.3.3 Protagonist Therapeutics Inc Integrin Alpha 4 Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Protagonist Therapeutics Inc Integrin Alpha 4 Product Portfolio
  18. 6.3.5 Protagonist Therapeutics Inc Recent Developments
  19. 6.4 Morphic Therapeutic Inc
  20. 6.4.1 Morphic Therapeutic Inc Company Information
  21. 6.4.2 Morphic Therapeutic Inc Business Overview
  22. 6.4.3 Morphic Therapeutic Inc Integrin Alpha 4 Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Morphic Therapeutic Inc Integrin Alpha 4 Product Portfolio
  24. 6.4.5 Morphic Therapeutic Inc Recent Developments
  25. 6.5 Immunwork Inc
  26. 6.5.1 Immunwork Inc Company Information
  27. 6.5.2 Immunwork Inc Business Overview
  28. 6.5.3 Immunwork Inc Integrin Alpha 4 Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Immunwork Inc Integrin Alpha 4 Product Portfolio
  30. 6.5.5 Immunwork Inc Recent Developments
  31. 6.6 EA Pharma Co Ltd
  32. 6.6.1 EA Pharma Co Ltd Company Information
  33. 6.6.2 EA Pharma Co Ltd Business Overview
  34. 6.6.3 EA Pharma Co Ltd Integrin Alpha 4 Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 EA Pharma Co Ltd Integrin Alpha 4 Product Portfolio
  36. 6.6.5 EA Pharma Co Ltd Recent Developments
  37. 6.7 Daiichi Sankyo Co Ltd
  38. 6.7.1 Daiichi Sankyo Co Ltd Company Information
  39. 6.7.2 Daiichi Sankyo Co Ltd Business Overview
  40. 6.7.3 Daiichi Sankyo Co Ltd Integrin Alpha 4 Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Daiichi Sankyo Co Ltd Integrin Alpha 4 Product Portfolio
  42. 6.7.5 Daiichi Sankyo Co Ltd Recent Developments
  43. 6.8 BioMAS Ltd
  44. 6.8.1 BioMAS Ltd Company Information
  45. 6.8.2 BioMAS Ltd Business Overview
  46. 6.8.3 BioMAS Ltd Integrin Alpha 4 Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 BioMAS Ltd Integrin Alpha 4 Product Portfolio
  48. 6.8.5 BioMAS Ltd Recent Developments
  49. 6.9 Biogen Inc
  50. 6.9.1 Biogen Inc Company Information
  51. 6.9.2 Biogen Inc Business Overview
  52. 6.9.3 Biogen Inc Integrin Alpha 4 Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Biogen Inc Integrin Alpha 4 Product Portfolio
  54. 6.9.5 Biogen Inc Recent Developments
  55. 6.10 Antisense Therapeutics Ltd
  56. 6.10.1 Antisense Therapeutics Ltd Company Information
  57. 6.10.2 Antisense Therapeutics Ltd Business Overview
  58. 6.10.3 Antisense Therapeutics Ltd Integrin Alpha 4 Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Antisense Therapeutics Ltd Integrin Alpha 4 Product Portfolio
  60. 6.10.5 Antisense Therapeutics Ltd Recent Developments
  61. 6.11 Amgen Inc
  62. 6.11.1 Amgen Inc Company Information
  63. 6.11.2 Amgen Inc Business Overview
  64. 6.11.3 Amgen Inc Integrin Alpha 4 Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Amgen Inc Integrin Alpha 4 Product Portfolio
  66. 6.11.5 Amgen Inc Recent Developments
7 North America by Country
  1. 7.1 North America Integrin Alpha 4 Sales by Country
  2. 7.1.1 North America Integrin Alpha 4 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Integrin Alpha 4 Sales by Country (2021-2026)
  4. 7.1.3 North America Integrin Alpha 4 Sales Forecast by Country (2027-2032)
  5. 7.2 North America Integrin Alpha 4 Market Size by Country
  6. 7.2.1 North America Integrin Alpha 4 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Integrin Alpha 4 Market Size by Country (2021-2026)
  8. 7.2.3 North America Integrin Alpha 4 Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Integrin Alpha 4 Sales by Country
  2. 8.1.1 Europe Integrin Alpha 4 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Integrin Alpha 4 Sales by Country (2021-2026)
  4. 8.1.3 Europe Integrin Alpha 4 Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Integrin Alpha 4 Market Size by Country
  6. 8.2.1 Europe Integrin Alpha 4 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Integrin Alpha 4 Market Size by Country (2021-2026)
  8. 8.2.3 Europe Integrin Alpha 4 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Integrin Alpha 4 Sales by Country
  2. 9.1.1 Asia-Pacific Integrin Alpha 4 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Integrin Alpha 4 Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Integrin Alpha 4 Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Integrin Alpha 4 Market Size by Country
  6. 9.2.1 Asia-Pacific Integrin Alpha 4 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Integrin Alpha 4 Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Integrin Alpha 4 Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Integrin Alpha 4 Sales by Country
  2. 10.1.1 South America Integrin Alpha 4 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Integrin Alpha 4 Sales by Country (2021-2026)
  4. 10.1.3 South America Integrin Alpha 4 Sales Forecast by Country (2027-2032)
  5. 10.2 South America Integrin Alpha 4 Market Size by Country
  6. 10.2.1 South America Integrin Alpha 4 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Integrin Alpha 4 Market Size by Country (2021-2026)
  8. 10.2.3 South America Integrin Alpha 4 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Integrin Alpha 4 Sales by Country
  2. 11.1.1 Middle East and Africa Integrin Alpha 4 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Integrin Alpha 4 Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Integrin Alpha 4 Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Integrin Alpha 4 Market Size by Country
  6. 11.2.1 Middle East and Africa Integrin Alpha 4 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Integrin Alpha 4 Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Integrin Alpha 4 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Integrin Alpha 4 Value Chain Analysis
  2. 12.1.1 Integrin Alpha 4 Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Integrin Alpha 4 Production Mode & Process
  7. 12.2 Integrin Alpha 4 Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Integrin Alpha 4 Distributors
  10. 12.2.3 Integrin Alpha 4 Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst